Article
Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.
Pharmacology & therapeutics - 1 Feb 2010
Kreindler James L
Abstract excerpt
Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel expressed in epithelial cells throughout the body. In the lungs, absence or dysfunction of CFTR results in altered epithelial salt and water transport eventuating in impaired mucociliary clearance, chronic infection and inflammation, and tissue damage. CF lung disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
